These systemic effects are uncommon and typically mild
So I wouldnt over think it ,just find your way through
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Can I combine GLOW Peptide Therapy with other treatments
Im excited about the potential for peptides, but we need the science to match the excitement, Frank said
If injected intravenously by itself (no drug dissolved), it can cause red blood cells to swell and lyse (burst) due to osmotic imbalance